Linden LLC

Linden Capital Partners Raises $355 Million for Structured Capital Fund

July 1, 2021 | For Immediate Release

Chicago, Illinois (July 1, 2021) – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, today announced the closing of its first structured capital fund. Linden Structured Capital Fund (“the Fund”) closed with $355 million of commitments, exceeding the Fund’s $250 million target.

“We’re excited to build on the firm’s 17-year track record of healthcare investments,” said Linden’s President and Managing Partner, Tony Davis. “This Fund allows Linden to leverage our firm’s knowledge and relationships to capitalize on further healthcare investments. We are thrilled about the market opportunity for the Fund.”

The Fund provides securities with debt and equity-like features to middle-market healthcare businesses. Scott Gallin, Linden’s Structured Capital Partner, said “As a structured capital provider exclusively focused on healthcare, we believe we are a value-added partner for equity sponsors and founders. Linden’s resources and experience enable us to move quickly and with certainty during diligence and in value creation.”

Linden’s Partner of Investor Relations, Katie Kornel, added “We are thankful for the support of Linden’s existing platform investors in this fundraise. In addition, we are pleased to add many new limited partner relationships to Linden, particularly in a virtual fundraise.”

Kirkland & Ellis LLP served as legal advisors and Park Hill Group LLC served as placement advisor.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies and has raised over $3 billion of commitments, augmented by capital provided by the firm’s limited partners for larger transactions. For more information, please visit